Indian medical devices more cost-effective: Union Minister
The Minister of State (independent charge) for Science and Technology was addressing the faculty and students after inaugurating the combined devices block at the Sree Chitra Tirunal Institute of Medical Sciences and Technology (SCTIMST) here. Technologies like the artificial heart valve, hydrocephalus shunt, oxygenator and drug-eluting intra-uterine device developed by the SCTIMST are being manufactured in countries like the USA, Japan, Brazil, and China, he said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 15, 2022 Category: Pharmaceuticals Source Type: news

Rhaeos, Inc. Receives FDA Breakthrough Device Designation for FlowSense(TM) Noninvasive Thermal Sensor
Novel wireless device designed to optimize shunt management in patients with hydrocephalus EVANSTON, Ill., June 1, 2020 -- (Healthcare Sales & Marketing Network) -- Rhaeos, Inc. (Rhaeos), a private medical technology company focused on addressing a cli... Devices, Monitoring, Neurosurgery, FDA Rhaeos , FlowSense, ventricular shunt, hydrocephalus (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - June 1, 2020 Category: Pharmaceuticals Source Type: news

Fewer infections with antibiotic-impregnated shunts for hydrocephalus
This NIHR Signal outlines the results of the BASICS study, which suggests that antibiotic-impregnated shunt catheters should be the first choice for people having a first ventriculoperitoneal shunt inserted for treatment of hydrocephalus, regardless of age or cause of illness. Although antibiotic-impregnated shunt catheters may not reduce the numbers of revisions required for any cause, infections in the cerebrospinal fluid cause significant morbidity and require longer and more expensive treatment as well as revision compared with just revision for mechanical failure.The authors say that the increased price of these shunt...
Source: Current Awareness Service for Health (CASH) - January 31, 2020 Category: Consumer Health News Source Type: news

Symposium Featured Pediatric Device Awards, Discussed Clinical Trial Possibilities
Six of the finalists competing in the “Make Your Medical Device Pitch for Kids!” program by Children’s National Hospital and the National Capital Consortium for Pediatric Device Innovation (NCC-PDI) were selected as winners during the 7th Annual Pediatric Device Innovation Symposium. Each company earned a $25,000 award and the opportunity to participate in NCC-PDI’s recently launched “Pediatric Device Innovator Accelerator Program” led by MedTech Innovator. In addition to celebrating pediatric device innovation, the ...
Source: MDDI - September 26, 2019 Category: Medical Devices Authors: Daphne Allen Tags: Design Source Type: news

Researchers question use of antibiotic shunts in hydrocephalus patients
Led by neurosurgeon Dr. Benjamin Warf, a team of researchers from Boston Children’s Hospital published a study this month questioning the benefits of using shunts impregnated with antibiotics to treat hydrocephalus. Hydrocephalus, which affects roughly 400,000 children each year, is characterized by fluid accumulation in the brain. Surgeons use shunts to drain the patient’s excess fluid and antibiotic shunts have become the standard of care in the U.S. Get the full story at our sister site, Drug Delivery Business News. The post Researchers question use of antibiotic shunts in hydrocephalus patients appeared first o...
Source: Mass Device - January 15, 2019 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Featured Neurological Pharmaceuticals Surgical Wall Street Beat Boston Children's Hospital Source Type: news

Experimental Skin Sensor May Warn of Hydrocephalus Shunt Failure Experimental Skin Sensor May Warn of Hydrocephalus Shunt Failure
A preliminary study suggests that a new skin sensor could help avoid life-threatening crises for the millions of people living with hydrocephalus, a condition that causes fluid to accumulate in the brain.Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - November 7, 2018 Category: Intensive Care Tags: Neurology & Neurosurgery News Source Type: news

Silicone Materials for Long-term Medical Implants: Innovate for the Future
By Feifei Lin, Ph.D., Business Development Manager, Healthcare, Elkem Silicones USA Corp. With the growth of the aging population, the number of age-related diseases has increased. Every year millions of patients sustained or improved their lives through surgical procedures involving implanted medical devices. Implants such as orthopedics, pacemakers, cardiovascular stents, defibrillators, neural prosthetics or combinational devices like drug-eluting stents have become an indispensable part of modern medicine. Long-term implantable devices used to improve and sustain life are highly regulated by regulatory bodies around th...
Source: Mass Device - October 5, 2018 Category: Medical Devices Authors: MassDevice Tags: Sponsored Content Source Type: news

ETV/CPC show positive outcomes in babies with hydrocephalus
Hydrocephalus, literally “water on the brain,” is an abnormal build-up of cerebrospinal fluid in the brain cavities known as ventricles. In infants, it can be congenital (it often accompanies spina bifida, for example), or it can be caused by brain hemorrhage or infection. The usual treatment is surgery to implant a shunt, which drains the excess fluid into the abdomen, relieving pressure on the brain. But over time, shunts nearly always fail, requiring emergency neurosurgery to repair or replace them. But emergency neurosurgery is not something that’s readily available outside of metropolitan areas. Untreated, hydro...
Source: Mass Device - July 24, 2018 Category: Medical Devices Authors: Danielle Kirsh Tags: Blog Vector Blog Source Type: news

Indian baby's head tripled in size due to hydrocephalus
Ankit Minj, from India, suffers from hydrocephalus - a build-up of fluid inside his skull which can be deadly. Doctors have inserted a shunt to remove some fluid. (Source: the Mail online | Health)
Source: the Mail online | Health - December 28, 2017 Category: Consumer Health News Source Type: news

Two surgical approaches equal in treating infection-caused hydrocephalus
(Penn State) Implanting a shunt or endoscopically reducing intracranial pressure and reducing fluid production are equally effective in treating infants with hydrocephalus caused by brain infections, according to an international team of researchers, but endoscopy may have fewer down-the-line complications. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 20, 2017 Category: International Medicine & Public Health Source Type: news

Daughter ’s neurosurgery inspires mom to give back
Danielle Parkman isn’t a doctor or nurse. In fact, she’s not a clinician of any kind. And yet every day she makes the lives of patients in the Boston Children’s Hospital Division of Pulmonary and Respiratory Diseases a little bit easier. As the Senior Administrative Associate for Pharmaceutical Benefits and Prior Authorization Specialist, Danielle is responsible for getting approvals for pharmacy benefits and prior authorizations for all pulmonology patients. It’s a daunting task, but she doesn’t take no for an answer. “I love my job, and I love fighting for my patients,” says Danielle. “I know I’m making...
Source: Thrive, Children's Hospital Boston - December 5, 2017 Category: Pediatrics Authors: Ellen Greenlaw Tags: Diseases & Conditions Our Patients’ Stories Department of Neurology Division of Pulmonary and Respiratory Diseases Hydrocephalus Hydrocephalus Program Source Type: news

Alcyone Lifesciences wins FDA nod for Alivio hydrocephalus shunt flusher
Alcyone Lifesciences said yesterday it won FDA 510(k) clearance for its Alivio ventricular catheter and flusher system designed for treating hydrocephalus. The newly cleared Alivio device is designed for the non-invasive retrograde flushing of the ventricular catheter to unblock occluded inlet holes or open a relief membrane to restore or increase cerebrospinal fluid flow in non-flowing shunts, the Lowell, Mass.-based company said. “For the first time in over half a century there has been a game changing improvement in the field of hydrocephalus treatment.  Ventricular shunting can help save lives and improve the qu...
Source: Mass Device - November 16, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Food & Drug Administration (FDA) Neurological Regulatory/Compliance Alcyone Lifesciences Source Type: news

7 medtech stories we missed this week: Oct. 27, 2017
[Image from]From RadiaDyne’s FDA expansion to NuVasive launching its new implants, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. FDA expands indications for RadiaDyne’s OARtrac dose monitor RadiaDyne announced in an Oct. 24 press release that it has received additional FDA clearance for its upcoming OARtrac. The OARtrac allows physicians to routinely monitor brachytherapy radiation dose as well as being able to reuse the OARtrac Plastic Scintillating Detector sensor cable no more than five times on one patient. 2. FDA clears Ortek’s electroni...
Source: Mass Device - October 27, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Catheters Dental Diagnostics Food & Drug Administration (FDA) Imaging Implants Neurological Research & Development Alcyone Lifesciences Implanet MedTech Nuvasive Ortek Therapeutics radiadyne Tau Consortium Varian Medical Syst Source Type: news

What Clinical Signs Can Be Associated With Benign External Hydrocephalus?
Discussion Hydrocephalus is an abnormal accumulation of cerebrospinal fluid (CSF) in the ventricles and/or subarachnoid spaces. External hydrocephalus is a communicating hydrocephalus often defined as the patient having a rapidly enlarging head circumference (HC) and enlargement of the subarachnoid spaces especially over the frontal lobes with normal or moderately enlarged ventricles. Benign external hydrocephalus (BEH) is a self-limited external hydrocephalus that occurs during infancy and resolves spontaneously in childhood, usually by age 2 years, that is felt to not cause significant problems. It was first described by...
Source: - October 2, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news +5 | The top 5 medtech stories for April 20, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. NuVasive launches Reline Trauma posterior fixation portfolio NuVasive Inc. said yesterday it launched its Reline Trauma spinal posterior fixation portfolio designed to aid in the preservation and restoration of patient alignmen...
Source: Mass Device - April 20, 2017 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news